Larry Lawson is a Founder and Executive Chairman at Proxima. He has 45+ years of experience in the healthcare industry.
He has been the founder, board member, and executive at several medical device companies: eCardio Diagnostics, Decisio Health, HeartcoR Solutions, and Preventice. He is an Angel Investor with the Goose Society, TMC Venture Fund, and Angel MD.
He is a Distinguished American Award recipient from the Horatio Alger Association.
Kevin Coker is a Co-Founder and the Chief Executive Officer at Proxima. He has 20+ years of experience in the healthcare industry.
He has been the founder, board member, and executive at several life science companies: Worldwide Clinical Trials, McKesson Corporation, and US Oncology.
Kevin is an attorney and is certified in regulatory affairs. He has worked with hundreds of pharmaceutical, biotech, and life science companies.
Dr. Jaye Thompson is a Co-Founder and the Chief Operating Officer at Proxima. She has 25+ years of experience in the healthcare industry.
She is an entrepreneur and has been an executive at several biotech companies: Synergos Inc (Founder, acquired by InVentiv Health), Opexa Therapeutics, and Repros Therapeutics.
Jaye is a biostatistician with clinical trial and regulatory expertise and has a history of assisting emerging companies meet their milestones.
Pamela Kennedy is the VP of Business Development for Proxima. She has 30+ years of experience in the healthcare industry.
She has served as an executive at several medical device CROs and companies, including: IQVIA, Novella Clinical, PPD, and Cyberonics (now LivaNova).
Pamela is a registered nurse in the field of clinical research with experience in medical devices, oncology, bone marrow and stem cell transplants, and neuromodulation products.
David Novotny is the Chief Strategy Officer for Proxima. He has 19 years of experience in the healthcare industry.
He has served as an operational executive at various medtech and life science companies, including: IQVIA, Novella Clinical, and Wound Solutions.
David is a trusted leader and strategist in the medical device and diagnostic industry and has been accountable for operational excellence and strategic planning.